Mast cell burden and reticulin fibrosis in the myeloproliferative neoplasms: A computer-assisted image analysis study

Akgul, 2004, Role of mast cells and their mediators in failing myocardium under mechanical ventricular support, J. Heart Lung Transplant, 23, 709, 10.1016/j.healun.2003.06.006 Bain, 1999, Systemic mastocytosis and other mast cell neoplasms, Br. J. Haematol., 106, 9, 10.1111/j.1365-2141.1999.01458.x Beham-Schmid, 2002, Treatment of chronic myelogenous leukemia with the tyrosine kinase inhibitor STI571 results in marked regression of bone marrow fibrosis, Blood, 99, 381, 10.1182/blood.V99.1.381 Crivellato, 2004, The mast cell: an active participant or an innocent bystander?, Histol. Histopathol., 19, 259 David, 2007, Durable responses to imatinib in patients with PDGFRB fusion gene-positive and BCR-ABL-negative chronic myeloproliferative disorders, Blood, 109, 61, 10.1182/blood-2006-05-024828 Dunphy, 2005, Evaluation of mast cells in myeloproliferative disorders and myelodysplastic syndromes, Arch. Pathol. Lab. Med., 129, 219, 10.5858/2005-129-219-EOMCIM Edwards, 2005, c-Kit immunophenotyping and metalloproteinase expression profiles of mast cells in interstitial lung diseases, J. Pathol., 206, 279, 10.1002/path.1780 Gallant-Behm, 2008, The mast cell stabilizer ketotifen prevents development of excessive skin wound contraction and fibrosis in red Duroc pigs, Wound Repair Regen., 16, 226, 10.1111/j.1524-475X.2008.00363.x Horny, 1997, Bone marrow mastocytosis associated with an undifferentiated extramedullary tumor of hemopoietic origin, Arch. Pathol. Lab. Med., 121, 423 Horny, 1985, Bone marrow findings in systemic mastocytosis, Hum. Pathol., 16, 808, 10.1016/S0046-8177(85)80252-5 Horny, 1990, Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders, Br. J. Haematol., 76, 186, 10.1111/j.1365-2141.1990.tb07870.x Hsu, 1981, Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures, J. Histochem. Cytochem., 29, 577, 10.1177/29.4.6166661 Ikura, 2005, Expression of angiotensin II type 1 receptor in human cirrhotic livers: its relation to fibrosis and portal hypertension, Hepatol. Res., 32, 107, 10.1016/j.hepres.2005.01.017 2001 Kakizoe, 2001, Isoform-selective upregulation of mast cell chymase in the development of skin fibrosis in scleroderma model mice, J. Invest. Dermatol., 116, 118, 10.1046/j.1523-1747.2001.00165.x Krishnaswamy, 2006, The human mast cell: an overview, Methods Mol. Biol., 315, 13 Lawrence, 1991, Hematologic manifestations of systemic mast cell disease: a prospective study of laboratory and morphologic features and their relation to prognosis, Am. J. Med., 91, 612, 10.1016/0002-9343(91)90214-I Lennert, 1979, Mast cells and mast cell neoplasia: a review, Histopathology, 3, 349, 10.1111/j.1365-2559.1979.tb03017.x Peart, 1975, Quantitative observations on iliac bone marrow mast cells in chronic renal failure, J. Clin. Pathol., 28, 947, 10.1136/jcp.28.12.947 Rasti, 2007, The comparison of diphenhydramine HCl and nedocromil sodium in prevention of abdominal postoperative adhesion formation in rat models: an experimental study, Int. J. Surg., 5, 384, 10.1016/j.ijsu.2007.04.013 Sotlar, 2008, J. Mol. Diagn., 10, 58, 10.2353/jmoldx.2008.070061 Tataroglu, 2007, Fibrosis in hodgkin and non-hodgkin lymphomas, Pathol. Res. Pract., 203, 725, 10.1016/j.prp.2007.07.006 Tefferi, 2005, Pathogenesis of myelofibrosis with myeloid metaplasia, J. Clin. Oncol., 23, 8520, 10.1200/JCO.2004.00.9316 Thiele, 2005, European consensus on grading bone marrow fibrosis and assessment of cellularity, Haematologica, 90, 1128 Travis, 1989, Solid and hematologic malignancies in 60 patients with systemic mast cell disease, Arch. Pathol. Lab. Med., 113, 365 Travis, 1988, Significance of systemic mast cell disease with associated hematologic disorders, Cancer, 62, 965, 10.1002/1097-0142(19880901)62:5<965::AID-CNCR2820620520>3.0.CO;2-M Valent, 1999, Recent advances in mastocytosis research. Summary of the Vienna mastocytosis meeting 1998, Int. Arch. Allergy Immunol., 120, 1, 10.1159/000024214 Webb, 1982, Systemic mast cell disease: a clinical and hematopathologic study of 26 cases, Cancer, 49, 927, 10.1002/1097-0142(19820301)49:5<927::AID-CNCR2820490517>3.0.CO;2-B Xu, 2002, Role of mast cells and myofibroblasts in human peritoneal adhesion formation, Ann. Surg., 236, 593, 10.1097/00000658-200211000-00009